Infanrix-hexa

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline, Laval University

Conditions

Hepatitis B

Phase 3

To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines

CompletedNCT00366366

GlaxoSmithKlineHepatitis B

Start: 2001-09-30End: 2002-09-30Updated: 2016-09-16

Phase 4

Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children

CompletedNCT04294433

Laval UniversityHepatitis B

Start: 2018-06-11End: 2023-12-30Updated: 2026-01-20